Cytomegalovirus Glycoprotein B Genotype in Patients with Anterior Segment Infection

(1) The glycoprotein B (gB) on the viral envelope, encoded by the most widely characterised polymorphic gene, gpUL55, is responsible for cytomegalovirus (CMV) entry into the host and could serve as a potential marker of pathogenicity. The aim of the present study is to investigate the distribution of the CMV gB genotype in anterior segment infection in Taiwan and its correlation with clinical manifestations and outcomes. (2) Fifty-seven patients with CMV anterior segment infection were identified according to clinical features and positivity for CMV DNA in aqueous humour samples. CMV gB genotyping was performed through polymerase chain reaction assays. Patients’ medical records were retrospectively reviewed. (3) Among the 57 aqueous humour samples tested for gB, 40 (70.28%) had multiple gB genotypes, and only 17 (29.82%) had a single gB genotype. Compared with single-genotype infection, multiple-genotype infection was correlated with higher CMV loads (p < 0.001) but not correlated with outcome. A higher proportion of patients with the gB3 genotype had received filtering surgery before antiviral treatment than those without the gB3 genotype (p = 0.046). (4) Multiple-genotype infection was highly prevalent in CMV anterior segment infection in Taiwan, and gB1 and gB3 were predominant. Multiple-genotype infection was correlated with higher CMV loads but not with specific clinical manifestations or prognostic outcomes. The gB3 genotype may be correlated with poor intraocular pressure control.

[1]  R. Agrawal,et al.  Clinical characteristics and treatment outcomes of Cytomegalovirus anterior uveitis and endotheliitis: a systematic review and meta-analysis. , 2021, Survey of ophthalmology.

[2]  B. Trusko,et al.  Classification criteria for cytomegalovirus anterior uveitis. , 2021, American journal of ophthalmology.

[3]  X. Kong,et al.  Polymorphisms of the cytomegalovirus glycoprotein B genotype in patients with Posner-Schlossman syndrome , 2021, British Journal of Ophthalmology.

[4]  Y. Hwang,et al.  Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results , 2021, Scientific reports.

[5]  M. Hummel,et al.  Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response , 2020, Frontiers in Cellular and Infection Microbiology.

[6]  G. Xiao,et al.  Clinical Evaluation of Intravitreal Injection of Ganciclovir in Refractory Corneal Endotheliitis , 2020, Ocular immunology and inflammation.

[7]  A. Jabłońska,et al.  Distribution of the CMV glycoprotein gH/gL/gO and gH/gL/pUL128/pUL130/pUL131A complex variants and associated clinical manifestations in infants infected congenitally or postnatally , 2019, Scientific Reports.

[8]  Travis L. Jensen,et al.  Cytomegalovirus genetic diversity following primary infection. , 2019, The Journal of infectious diseases.

[9]  F. Rozenberg,et al.  Cytomegalovirus Anterior Uveitis: Clinical Characteristics and Long-term Outcomes in a French Series. , 2018, American journal of ophthalmology.

[10]  J. Shu,et al.  Prevalence and clinical consequences of cytomegalovirus DNA in the aqueous humour and corneal transplants , 2018, British Journal of Ophthalmology.

[11]  M. Ciccozzi,et al.  Cytomegalovirus Glycoprotein B Genotype Distribution in Italian Transplant Patients , 2018, Intervirology.

[12]  D. Nowakowska,et al.  Human cytomegalovirus UL55, UL144, and US28 genotype distribution in infants infected congenitally or postnatally , 2015, Journal of medical virology.

[13]  Y. Ohashi,et al.  Polymorphisms in cytomegalovirus genotype in immunocompetent patients with corneal endotheliitis or iridocyclitis , 2015, Journal of medical virology.

[14]  Tsing-Hong Wang,et al.  Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. , 2014, American journal of ophthalmology.

[15]  N. Koizumi,et al.  Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study , 2014, British Journal of Ophthalmology.

[16]  J. Otte,et al.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis , 2013, Medical Microbiology and Immunology.

[17]  A. Davenport,et al.  Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial , 2011, The Lancet.

[18]  S. Chee,et al.  Cytomegalovirus anterior uveitis: outcome of treatment , 2010, British Journal of Ophthalmology.

[19]  A. Sun,et al.  Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  K. Maruyama,et al.  A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uveitis , 2009, British Journal of Ophthalmology.

[21]  E. Puchhammer-Stöckl,et al.  Virus load dynamics of individual CMV‐genotypes in lung transplant recipients with mixed‐genotype infections , 2008, Journal of medical virology.

[22]  S. Chee,et al.  Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. , 2008, American journal of ophthalmology.

[23]  N. Koizumi,et al.  Cytomegalovirus as an etiologic factor in corneal endotheliitis. , 2008, Ophthalmology.

[24]  A. Varin,et al.  Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  T. Lazzarotto,et al.  Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  Deepali Kumar,et al.  Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. , 2003, The Journal of infectious diseases.

[27]  A. Tenório,et al.  Different Cytomegalovirus Glycoprotein B Genotype Distribution in Serum and Cerebrospinal Fluid Specimens Determined by a Novel Multiplex Nested PCR , 2003, Journal of Clinical Microbiology.

[28]  A. Humar,et al.  Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[29]  M. Barbi,et al.  CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  V. Aquino,et al.  High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype , 2000 .

[31]  E. Mocarski,et al.  Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Lipson,et al.  A fifth human cytomegalovirus glycoprotein B genotype. , 1998, Research in virology.

[33]  W. Leisenring,et al.  Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. , 1997, Blood.

[34]  S. Lipson,et al.  Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. , 1996, The Journal of infectious diseases.

[35]  P. Paz,et al.  Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. , 1993, Virology.

[36]  S. Chou,et al.  Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. , 1991, The Journal of infectious diseases.

[37]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[38]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[39]  A. Dick,et al.  The Standardization of Uveitis Nomenclature (SUN) Project , 2013, Methods of Information in Medicine.

[40]  Chi-Chun Lai,et al.  The validity of clinical feature profiles for cytomegaloviral anterior segment infection , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[41]  N. Câmara,et al.  Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients. , 2009, International immunopharmacology.

[42]  V. Aquino,et al.  High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. , 2000, Journal of medical virology.